Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
Clinical trial NCT03974113 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03974113
- Sponsor
- Genzyme, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-28
- Primary completion
- 2026-08-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.